Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors
- PMID: 10577510
- DOI: 10.1002/jlb.66.5.781
Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors
Abstract
In vivo, dendritic cells (DC) form a network comprising different populations. In particular, Langerhans cells (LC) appear as a unique population of cells dependent on transforming growth factor beta(TGF-beta) for its development. In this study, we show that endogenous TGF-beta is required for the development of both LC and non-LC DC from CD34+ hematopoietic progenitor cells (HPC) through induction of DC progenitor proliferation and of CD1a+ and CD14+ DC precursor differentiation. We further demonstrate that addition of exogenous TGF-beta polarized the differentiation of CD34+ HPC toward LC through induction of differentiation of CD14+ DC precursors into E-cadherin+, Lag+CD68-, and Factor XIIIa-LC, displaying typical Birbeck granules. LC generated from CD34+ HPC in the presence of exogenous TGF-beta displayed overlapping functions with CD1a+ precursor-derived DC. In particular, unlike CD14(+)-derived DC obtained in the absence of TGF-beta, they neither secreted interleukin-10 (IL-10) on CD40 triggering nor stimulated the differentiation of CD40-activated naive B cells. Finally, IL-4, when combined with granulocyte-macrophage colony-stimulating factor (GM-CSF), induced TGF-beta-independent development of non-LC DC from CD34+ HPC. Similarly, the development of DC from monocytes with GM-CSF and IL-4 was TGF-beta independent. Collectively these results show that TGF-beta polarized CD34+ HPC differentiation toward LC, whereas IL-4 induced non-LC DC development independently of TGF-beta.
Similar articles
-
CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner.J Immunol. 1999 Nov 1;163(9):4869-77. J Immunol. 1999. PMID: 10528188
-
Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells.Blood. 1996 Mar 15;87(6):2376-85. Blood. 1996. PMID: 8630401
-
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.J Exp Med. 1996 Aug 1;184(2):695-706. doi: 10.1084/jem.184.2.695. J Exp Med. 1996. PMID: 8760823 Free PMC article.
-
[The Langerhans cell: from in vitro production to use in cellular immunotherapy].J Soc Biol. 2001;195(1):69-74. J Soc Biol. 2001. PMID: 11530504 Review. French.
-
[In vitro differenciation and functions of dendritic cells obtained from CD34+ hematopoietic progenitors].Pathol Biol (Paris). 1995 Dec;43(10):829-40. Pathol Biol (Paris). 1995. PMID: 8786887 Review. French.
Cited by
-
Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells.Br J Cancer. 2001 Dec 14;85(12):1944-51. doi: 10.1054/bjoc.2001.2183. Br J Cancer. 2001. PMID: 11747338 Free PMC article.
-
Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.J Virol. 2011 Jul;85(14):7465-71. doi: 10.1128/JVI.00088-11. Epub 2011 May 18. J Virol. 2011. PMID: 21593144 Free PMC article.
-
Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation.J Exp Med. 2013 Nov 18;210(12):2597-610. doi: 10.1084/jem.20130275. Epub 2013 Nov 4. J Exp Med. 2013. PMID: 24190429 Free PMC article.
-
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.Springer Semin Immunopathol. 2000;22(4):345-69. doi: 10.1007/s002810000053. Springer Semin Immunopathol. 2000. PMID: 11155441 Review.
-
Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.Cancer Immunol Immunother. 2005 Sep;54(9):898-906. doi: 10.1007/s00262-004-0652-3. Epub 2005 Mar 18. Cancer Immunol Immunother. 2005. PMID: 15776284 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials